Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and nonmotor symptoms. The impaired ability to recognize facial emotion expressions represents an important nonmotor symptom. The aim of this study is to investigate the ability in recognizing facial emotion expressions in patients with PD under dopamine replacement therapy.
Methods:
Thirty medicated patients with PD and 15 healthy controls (HC) were enrolled. All participants performed the Ekman 60-Faces test for emotional recognition. All patients underwent a neuropsychological evaluation for global cognitive functioning, depression, and anxiety.
Results:
Patients with PD were impaired in recognizing emotions. Significant differences between PD and HC were found in Ekman 60-Faces test scores (P < .001), and in Ekman 60-Faces test subscales, in particular, sadness, fear, disgust, anger, and surprise (P < .001).
Conclusions:
The nigrostriatal dopaminergic depletion seems to determine emotional information processing dysfunction. This relevant nonmotor symptom could have consequences in daily living reducing interactions and social behavioral competence.
Van AndelJFDRGabreelsFJMGeurtzB, et al.l-Dopa–responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency. Neurology. 2000;55(12):1926–1928.
2.
NarmePBonnetAMDuboisBChabyL. Understanding facial emotion perception in Parkinson’s disease: the role of configural processing. Neuropsychologia. 2011;49(12):3295–3302.
3.
XiCZhuYMuY, et al.Theory of mind and decision-making processes are impaired in Parkinson’s disease. Behav Brain Res. 2015;279:226–233.
4.
PalmeriRLo BuonoVCoralloF, et al.Non-motor symptoms in Parkinson disease: a descriptive review on social cognition ability. J Geriatr Psychiatry Neurol. 2017;30(2):109–121.
5.
AndersonRJSimpsonACChannonSSamuelMBrownRG. Social problem solving, social cognition, and mild cognitive impairment in Parkinson’s disease. Behav Neurosci. 2013;127(2):184.
6.
WhittingtonCJPoddJKannMM. Recognition memory impairment in Parkinson’s disease: power and meta-analyses. Neuropsychology. 2000;14(2):233–246.
7.
DirnbergerGJahanshahiM. Executive dysfunction in Parkinson’s disease: a review. J Neuropsychol. 2013;7(2):193–224.
8.
CrucianGPOkunMS. Visuo-spatial ability in Parkinson’s disease. Front Biosci. 2003;8:992–997.
9.
EnriciIAdenzatoMArditoRB, et al.Emotion processing in Parkinson’s disease: a three-level study on recognition, representation, and regulation. PLoS One. 2015;10(6):e0131470.
10.
CiurleoRCoralloFBonannoL, et al.Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson’s disease and their caregivers. J Neurol. 2018;265(9):1–10.
11.
SprengelmeyerRYoungAWMahnK, et al.Facial expression recognition in people with medicated and unmedicated Parkinson’s disease. Neuropsychology. 2003;41(8):1047–1057.
12.
DaraCMonettaLPellMD. Vocal emotions processing in Parkinson’s disease: reduced sensitivity to negative emotions. Brain Res. 2008;1188:100–111.
13.
BreitensteinCVan LanckerDDaulIWatersCH. Impaired perception of vocal emotions in Parkinson’s disease: influence of speech time processing and executive functioning. Brain Cognit. 2011;45(2):277–314.
14.
Fusar-PoliPPlacentinoACarlettiF, et al.Functional atlas of emotional faces processing: a voxel-based meta-analyses of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci. 2009;34(6):418–432.
15.
AssognaFPontieriFECaltagironeCSpallettaG. The recognition of facial emotion expressions in Parkinson’s disease. Eur Neuropsychopharmacol. 2008;18(11):835–848.
16.
KeaneJCalderAHodgesJYoungA. Face and emotion processing in frontal variant frontotemporal dementia. Neuropsychology. 2002;40(6):655–665.
17.
BraakHGhebremedhinERubUBratzkeHDel TrediciK. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res. 2004;318(1):121–134.
18.
RossiMGerschcovichERDe AchavalD, et al.Decision-making in Parkinson’s disease patients with and without pathological gambling. Euro J Neurol. 2010;17(1):97–102.
19.
LawrenceADGoerendtIKBrooksDJ. Impaired recognition of facial expressions of anger in Parkinson’s disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychology. 2007;45(1):65–74.
20.
FahnSEltonRL; the members of the UPDRS Development Committee. The Unified Parkinson’s Disease Rating Scale. In FahnS.MarsdenCD.CalneDB.GoldsteinM. eds. Recent Developments in Parkinson’s Disease. Vol. 2. Florham Park, NJ: Macmillan Healthcare; 1987. 153–163.
21.
GibbWRGLeesA. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51(6):745–752.
22.
FolsteinMFFolsteinSEMcHughPR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–198.
23.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Washington: American Psychiatric Pub; 2013.
24.
YesavageJABrinkTLRoseTL, et al.Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatric Res. 1982;17(1):37–49.
25.
Hoehn YahrMD. Parkinsonism: onset progression and mortality. Neurology. 1996;17(5):427–442.
26.
MioshiEDawsonKMitchellJArnoldRHodgesJR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21(11):1078–1085.
27.
HamiltonMAX. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55.
SprengelmeyerRYoungAWPundtI, et al.Disgust implicated in obsessive–compulsive disorder. Proc Biol Sci. 1997;264(1389):1767–1773.
30.
ArgaudSVérinMSauleauPGrandjeanD. Facial emotion recognition in Parkinson’s disease: a review and new hypotheses. Mov Disord. 2018;33(4):554–567.
31.
JacobsDHShurenJBowersDHeilmanKM. Emotional facial imagery, perception, and expression in Parkinson’s disease. Neurology. 1995;45(9):1696–1702.
32.
HardingAJStimsonEHendersonJMHallidayGM. Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain. 2002;125(11):2431–2445.
33.
Nagano-SaitoAWashimiYArahataY, et al.Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology. 2005;64(2):224–229.
34.
PéronJDondaineTLe JeuneFGrandjeanDVérinM. Emotional processing in Parkinson’s disease: a systematic review. Mov Disord. 2012;27(2):186–199.
35.
PeronJGrandjeanDDrapierSVerinM. Effect of dopamine therapy on nonverbal affect burst recognition in Parkinson’s disease. Fleming S, editor. PLoS One; 2014;9(3):e90092.
36.
ScottSCairdFIWilliamsBO. Evidence for an apparent sensory speech disorder in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1984;47(8):840–843.
37.
BeattyWWGoodkinDEWeirWSStatonRDMonsonNBeattyPA. Affective judgments by patients with Parkinson’s disease or chronic progressive multiple sclerosis. Bull Psychonom Soc. 1989;27(4):361–364.
38.
DujardinKBlairySDefebvreL, et al.Deficits in decoding emotional facial expressions in Parkinson’s disease. Neuropsychology. 2004;42(2):239–250.
39.
BlonderLXSlevinJTKryscioRJ, et al.Dopaminergic modulation of memory and affective processing in Parkinson depression. Psychiatry Res. 2013;210(1):146–149.
40.
DewickHCHanleyJRDaviesADMPlayferJTurnbullC. Perception and memory for faces in Parkinson’s disease. Neuropsychology. 1991;29(8):785–802.
41.
MadeleyPEllisAWMindhamRHS. Facial expressions and Parkinson’s disease. Behav Neurol. 1995;8(2):115–119.
42.
AdolphsRSchulRTranelD. Intact recognition of facial emotion in Parkinson’s disease. Neuropsychol. 1998;12(2):253.
43.
PellMDCheangHSLeonardCL. The impact of Parkinson’s disease on vocal-prosodic communication from the perspective of listeners. Brain Lang. 2006;97(2):123–134.
44.
BennettMRHackerPMS. Emotion and cortical-subcortical function: conceptual developments. Prog Neurobiol. 2005;75(1):29–52.
45.
DelaveauPSalgado-PinedaPWitjasT, et al.Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease. J Clin Psychopharm. 2009;29(6):548–554.
46.
VicenteSBiseulIPéronJ, et al.Subthalamic nucleus stimulation affects subjective emotional experience in Parkinson’s disease patients. Neuropsychology. 2009;47(8-9):1928–1937.
47.
PéronJBiseulILerayE, et al.Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson’s disease. Neuropsychology. 2010;24(1):1.
48.
KumforFIrishMHodgesJRPiguetO. Discrete neural correlates for the recognition of negative emotions: insights from frontotemporal dementia. PLoS One. 2013;8(6):e67457.
49.
CalderAJKeaneJManesFAntounNYoungAW. Impaired recognition and experience of disgust following brain injury. Nat Neurosci. 2000;3(11):1077.
50.
SprengelmeyerRYoungAWSchroederU, et al.Knowing no fear. Proc R Soc Lond B Biol Sci. 1999;266(1437):2451–2456.
51.
AdolphsRTranelDDamasioAR. Dissociable neural systems for recognizing emotions. Brain Cognit. 2003;52(1):61–69.
52.
VirtanenMSingh-ManouxA, et al.The level of cognitive function and recognition of emotions in older adults. PLoS One. 2017;12(10):e0185513.
53.
BrownLLSchneiderJSLidskyTI. Sensory and cognitive functions of the basal ganglia. Curr Opin Neurobiol. 1997;7(2):157–163.
54.
XieCBaiFYuH, et al.Abnormal insula functional network is associated with episodic memory decline in amnestic mild cognitive impairment. Neuroimage. 2012;63(1):320–327.
55.
AllenJSEmmoreyKBrussJDamasioH. Morphology of the insula in relation to hearing status and sign language experience. J Neurosci. 2008;28(46):11900–11905.
56.
AssognaFPontieriFCravelloL, et al.Intensity-dependent facial emotion recognition and cognitive functions in Parkinson’s disease. J Int Neuropsychol Soc. 2010;16(5):867–876.
57.
HerreraECuetosFRodríguez-FerreiroJ. Emotion recognition impairment in Parkinson’s disease patients without dementia. J Neurol Sci. 2011;310(1-2):237–240.
58.
Van TrichtMJSmedingHMSpeelmanJDSchmandBA. Impaired emotion recognition in music in Parkinson’s disease. Brain Cognit. 2010;74(1):58–65.
59.
PolettiMFrosiniDPagniCLucettiCDel DottoPCeravoloR, et al.Alexithymia is associated with depression in de novo Parkinson’s disease. Psychother Psychosom. 2011;80(4):251–253. doi:10.1159/ 000322029. PMID: 21546783
60.
SagnaAGalloJJPontoneGM. Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:708–715. doi:10.1016/j.parkreldis.2014.03.020. PMID: 24780824.2014
61.
BoddenMEMollenhauerBTrenkwalderC, et al.Affective and cognitive theory of mind in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(7):466–470. doi:10.1016/j.parkreldis.2010.04.014. PMID: 20538499
62.
ParentAHazratiLN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external palladium in basal ganglia circuitry. Brain Res Rev. 1995;20(1):128–154.
63.
CoralloFDe ColaMCLo BuonoVDi LorenzoGBramantiPMarinoS. Observational study of quality of life of Parkinson’s patients and their caregivers. Psychogeriatric. 2017;17(2):97–102.
64.
GrayHMTickle-DegnenL. A meta-analysis of performance on emotion recognition tasks in Parkinson’s disease. Neuropsychol. 2010;24(2):176.
